Sun Pharmaceutical Industries Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 118,133.3 million compared to INR 107,255.7 million a year ago. Revenue was INR 1,258,884 million compared to INR 113,039.5 million a year ago. Net income was INR 26,545.8 million compared to INR 19,844.7 million a year ago. Basic earnings per share from continuing operations was INR 11.1 compared to INR 8.3 a year ago. Diluted earnings per share from continuing operations was INR 11.1 compared to INR 8.3 a year ago.
For the full year, sales was INR 477,584.5 million compared to INR 432,788.7 million a year ago. Revenue was INR 498,510.4 million compared to INR 445,202 million a year ago. Net income was INR 95,763.8 million compared to INR 84,735.8 million a year ago. Basic earnings per share from continuing operations was INR 39.9 compared to INR 35.3 a year ago. Diluted earnings per share from continuing operations was INR 39.9 compared to INR 35.3 a year ago.